Jean-Baptiste Belge, MD, PhD, specializes in neuromodulation and advanced psychopharmacology for difficult-to-treat neuropsychiatric disorders and conducts research into the neurobiology underlying these techniques. Using advanced methods such as fMRI, DTI, and machine learning, Dr. Belge investigates the effects of these treatments on brain activity and structure. Through a holistic approach that integrates multiple research methodologies, his work provides insight into the complex interaction between neuromodulation techniques and the intricate neural networks of the human brain, leading to the development of new therapeutic applications.

He completed intensive studies at the Université catholique de Louvain, KU Leuven, University of Antwerp, and Radboud University. By combining clinical expertise with advanced research, he provides individualized and effective treatments. Dr. Belge’s dedication to advancing the field has earned him recognition, including an award from the Royal Academy of Medicine of Belgium.